000 01376 a2200361 4500
005 20250517172535.0
264 0 _c20180508
008 201805s 0 0 eng d
022 _a1536-0229
024 7 _a10.1097/RLU.0000000000001820
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUlaner, Gary A
245 0 0 _a89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.
_h[electronic resource]
260 _bClinical nuclear medicine
_cDec 2017
300 _a912-917 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aBreast Neoplasms
_xdiagnostic imaging
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aPositron Emission Tomography Computed Tomography
650 0 4 _aProspective Studies
650 0 4 _aReceptor, ErbB-2
_xmetabolism
700 1 _aHyman, David M
700 1 _aLyashchenko, Serge K
700 1 _aLewis, Jason S
700 1 _aCarrasquillo, Jorge A
773 0 _tClinical nuclear medicine
_gvol. 42
_gno. 12
_gp. 912-917
856 4 0 _uhttps://doi.org/10.1097/RLU.0000000000001820
_zAvailable from publisher's website
999 _c27528637
_d27528637